檢索結果 - Roberta Alfieri
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
The Translational Machinery of Human CD4+ T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic Remodeling 由 Sara Ricciardi, Nicola Manfrini, Roberta Alfieri, Piera Calamita, Mariacristina Crosti, Simone Gallo, Rolf Müller, Massimiliano Pagani, Sergio Abrignani, Stefano Biffo
出版 2018Artigo -
7
-
8
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells 由 Daniele Cretella, Claudia Fumarola, Mara Bonelli, Roberta Alfieri, Silvia La Monica, Graziana Digiacomo, Andrea Cavazzoni, Maricla Galetti, Daniele Generali, Pier Giorgio Petronini
出版 2019Artigo -
9
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review 由 Alessandro Leonetti, Roberta Minari, Giulia Mazzaschi, Letizia Gnetti, Silvia La Monica, Roberta Alfieri, Nicoletta Campanini, Michela Verzè, Andrea Olivani, Luigi Ventura, Marcello Tiseo
出版 2021Artigo -
10
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells 由 Daniele Cretella, Andrea Ravelli, Claudia Fumarola, Silvia La Monica, Graziana Digiacomo, Andrea Cavazzoni, Roberta Alfieri, Alessandra Biondi, Daniele Generali, Mara Bonelli, Pier Giorgio Petronini
出版 2018Artigo -
11
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report 由 Karim Rihawi, Roberta Alfieri, Michelangelo Fiorentino, Francesca Fontana, Elisa Capizzi, Andrea Cavazzoni, Mario Terracciano, Silvia La Monica, Alberto Ferrarini, Genny Buson, Pier Giorgio Petronini, Andrea Ardizzoni
出版 2018Artigo -
12
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines 由 Silvia La Monica, Daniele Cretella, Mara Bonelli, Claudia Fumarola, Andrea Cavazzoni, Graziana Digiacomo, Lisa Flammini, Elisabetta Barocelli, Roberta Minari, Nadia Naldi, Pier Giorgio Petronini, Marcello Tiseo, Roberta Alfieri
出版 2017Artigo -
13
Efficacy of the CDK4/6 Dual Inhibitor Abemaciclib in EGFR-Mutated NSCLC Cell Lines with Different Resistance Mechanisms to Osimertinib 由 Silvia La Monica, Claudia Fumarola, Daniele Cretella, Mara Bonelli, Roberta Minari, Andrea Cavazzoni, Graziana Digiacomo, Maricla Galetti, Francesco Volta, Maicol Mancini, Pier Giorgio Petronini, Marcello Tiseo, Roberta Alfieri
出版 2020Artigo -
14
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines 由 Silvia La Monica, Maricla Galetti, Roberta Alfieri, Andrea Cavazzoni, Andrea Ardizzoni, Marcello Tiseo, Marzia Capelletti, Matteo Goldoni, Sara Tagliaferri, Antonio Mutti, Claudia Fumarola, Mara Bonelli, Daniele Generali, Pier Giorgio Petronini
出版 2009Artigo -
15
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines 由 Maricla Galetti, Pier Giorgio Petronini, Claudia Fumarola, Daniele Cretella, Silvia La Monica, Mara Bonelli, Andrea Cavazzoni, Francesca Saccani, Cristina Caffarra, Roberta Andreoli, Antonio Mutti, Marcello Tiseo, Andrea Ardizzoni, Roberta Alfieri
出版 2015Artigo -
16
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility 由 Andrea Ravelli, Giandomenico Roviello, Daniele Cretella, Andrea Cavazzoni, Alessandra Biondi, Maria Rosa Cappelletti, Laura Zanotti, Giuseppina Ferrero, Marco Ungari, Fabrizio Zanconati, Alberto Bottini, Roberta Alfieri, Pier Giorgio Petronini, Daniele Generali
出版 2017Revisão -
17
Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer 由 Andrea Cavazzoni, Graziana Digiacomo, Roberta Alfieri, Silvia La Monica, Claudia Fumarola, Maricla Galetti, Mara Bonelli, Daniele Cretella, Valeria Barili, Alessandra Zecca, Elisa Giovannetti, Michelangelo Fiorentino, Marcello Tiseo, Pier Giorgio Petronini, Andrea Ardizzoni
出版 2020Artigo -
18
Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress 由 Roberta Alfieri, Mara Bonelli, Andrea Cavazzoni, Maurizio Brigotti, Claudia Fumarola, Piero Sestili, Paola Mozzoni, Giuseppe De Palma, Antonio Mutti, Domenica Carnicelli, Federica Vacondio, Claudia Silva, Angelo F. Borghetti, Kenneth P. Wheeler, Pier Giorgio Petronini
出版 2006Artigo -
19
Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification 由 Silvia La Monica, Cristina Caffarra, Francesca Saccani, Elena Galvani, Maricla Galetti, Claudia Fumarola, Mara Bonelli, Andrea Cavazzoni, Daniele Cretella, Rita Sirangelo, Rita Gatti, Marcello Tiseo, Andrea Ardizzoni, Elisa Giovannetti, Pier Giorgio Petronini, Roberta Alfieri
出版 2013Artigo -
20
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell L... 由 Claudia Fumarola, Nicole Bozza, Riccardo Castelli, Francesca Ferlenghi, Giuseppe Marseglia, Alessio Lodola, Mara Bonelli, Silvia La Monica, Daniele Cretella, Roberta Alfieri, Roberta Minari, Maricla Galetti, Marcello Tiseo, Andrea Ardizzoni, Marco Mor, Pier Giorgio Petronini
出版 2019Artigo
相關主題
Medicine
Biology
Cancer research
Cancer
Internal medicine
Biochemistry
Epidermal growth factor receptor
Genetics
Gefitinib
Lung cancer
Oncology
Chemistry
Cell biology
Gene
Breast cancer
Immunology
Erlotinib
Apoptosis
Cell growth
Chemotherapy
Osimertinib
Pathology
Pharmacology
Receptor
T790M
Cell cycle
Immune system
Metastatic breast cancer
PI3K/AKT/mTOR pathway
Palbociclib